670 related articles for article (PubMed ID: 12803123)
1. Type I Gaucher's disease with homozygous R463C mutation without neurological involvement.
Bolaman Z; Kadikoylu G; Levi E; Barutca S; Temucin K
Haematologia (Budap); 2002; 32(4):487-93. PubMed ID: 12803123
[TBL] [Abstract][Full Text] [Related]
2. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene.
Tybulewicz VL; Tremblay ML; LaMarca ME; Willemsen R; Stubblefield BK; Winfield S; Zablocka B; Sidransky E; Martin BM; Huang SP
Nature; 1992 Jun; 357(6377):407-10. PubMed ID: 1594045
[TBL] [Abstract][Full Text] [Related]
3. Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease.
Schmitz M; Alfalah M; Aerts JM; Naim HY; Zimmer KP
Int J Biochem Cell Biol; 2005 Nov; 37(11):2310-20. PubMed ID: 15982918
[TBL] [Abstract][Full Text] [Related]
4. [Genetics of Gaucher's disease. Genotype-phenotype correlation].
Alfonso Palacín P; Pocoví M
Med Clin (Barc); 2011 Sep; 137 Suppl 1():17-22. PubMed ID: 22230121
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of Turkish Gaucher disease patients: identification of novel mutations in glucocerebrosidase (GBA) gene.
Emre S; Gürakan F; Yüce A; Rolf A; Scott R; Ozen H
Eur J Med Genet; 2008; 51(4):315-21. PubMed ID: 18586596
[TBL] [Abstract][Full Text] [Related]
6. RecTL: a complex allele of the glucocerebrosidase gene associated with a mild clinical course of Gaucher disease.
Zimran A; Horowitz M
Am J Med Genet; 1994 Mar; 50(1):74-8. PubMed ID: 8160756
[TBL] [Abstract][Full Text] [Related]
7. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease.
Tsuji S; Choudary PV; Martin BM; Stubblefield BK; Mayor JA; Barranger JA; Ginns EI
N Engl J Med; 1987 Mar; 316(10):570-5. PubMed ID: 2880291
[TBL] [Abstract][Full Text] [Related]
8. Gaucher disease in Romanian patients: incidence of the most common mutations and phenotypic manifestations.
Drugan C; Procopciuc L; Jebeleanu G; Grigorescu-Sido P; Dussau J; Poenaru L; Caillaud C
Eur J Hum Genet; 2002 Sep; 10(9):511-5. PubMed ID: 12173027
[TBL] [Abstract][Full Text] [Related]
9. Homozygous loss of a cysteine residue in the glucocerebrosidase gene results in Gaucher's disease with a hydropic phenotype.
Church HJ; Cooper A; Stewart F; Thornton CM; Wraith JE
Eur J Hum Genet; 2004 Nov; 12(11):975-8. PubMed ID: 15292921
[TBL] [Abstract][Full Text] [Related]
10. [Type 1 Gaucher disease in a pediatric patient: 12 year's evolution].
García M; Casanova C; Chabás A; Viosca E; Martínez B
Sangre (Barc); 1997 Jun; 42(3):227-9. PubMed ID: 9381267
[TBL] [Abstract][Full Text] [Related]
11. Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.
Choy FY; Zhang W; Shi HP; Zay A; Campbell T; Tang N; Ferreira P
Blood Cells Mol Dis; 2007; 38(3):287-93. PubMed ID: 17196853
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis in 46 British and Irish patients with Gaucher's disease.
Hatton CE; Cooper A; Whitehouse C; Wraith JE
Arch Dis Child; 1997 Jul; 77(1):17-22. PubMed ID: 9279145
[TBL] [Abstract][Full Text] [Related]
13. Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher's disease.
Tayebi N; Reissner KJ; Lau EK; Stubblefield BK; Klineburgess AC; Martin BM; Sidransky E
Pediatr Res; 1998 May; 43(5):571-8. PubMed ID: 9585001
[TBL] [Abstract][Full Text] [Related]
14. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.
Stone DL; Tayebi N; Orvisky E; Stubblefield B; Madike V; Sidransky E
Hum Mutat; 2000; 15(2):181-8. PubMed ID: 10649495
[TBL] [Abstract][Full Text] [Related]
15. [Gaucher's disease with D409H/D409H genotype. evolution with enzyme replacement therapy].
Castelló Girona F; Domínguez Luengo C; del Toro Riera M; Chabás Bergon A
An Esp Pediatr; 2001 Mar; 54(3):310-2. PubMed ID: 11262263
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients.
Suwannarat P; Keeratichamroen S; Wattanasirichaigoon D; Ngiwsara L; Cairns JR; Svasti J; Visudtibhan A; Pangkanon S
Blood Cells Mol Dis; 2007; 39(3):348-52. PubMed ID: 17689991
[TBL] [Abstract][Full Text] [Related]
17. Glucocerebrosidase genotype of Gaucher patients in The Netherlands: limitations in prognostic value.
Boot RG; Hollak CE; Verhoek M; Sloof P; Poorthuis BJ; Kleijer WJ; Wevers RA; van Oers MH; Mannens MM; Aerts JM; van Weely S
Hum Mutat; 1997; 10(5):348-58. PubMed ID: 9375849
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
[TBL] [Abstract][Full Text] [Related]
19. Beta-glucocerebrosidase gene locus as a link for Gaucher's disease and familial hypo-alpha-lipoproteinaemia.
Pocovi M; Cenarro A; Civeira F; Torralba MA; Perez-Calvo JI; Mozas P; Giraldo P; Giralt M; Myers RH; Cupples LA; Ordovas JM
Lancet; 1998 Jun; 351(9120):1919-23. PubMed ID: 9654259
[TBL] [Abstract][Full Text] [Related]
20. [Gene therapy of Gaucher's and Fabry's diseases: current status and prospects].
Fabrega S; Lehn P
J Soc Biol; 2002; 196(2):175-81. PubMed ID: 12360746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
